Tedizolid Receives Qualified Infectious Disease Product (QIDP) Designation From FDA

[at noodls] – FDA’s Action Expedites Regulatory Review Process of the New Drug Application (NDA) SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused … more

View todays social media effects on TSRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Trius is hiring next, click here to view